| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |